Health insurance policies; required to offer nonstatin medication for heart attack prevention.

SB 2414, a proposed Mississippi bill, would have required health insurance plans (including individual, group, and managed care plans) delivered or renewed after July 1, 2025, to cover nonstatin medications specifically approved for reducing heart attack risk in both primary prevention (preventing first events) and secondary prevention (preventing recurrence) patients. It would have mandated this coverage at the same cost-sharing level (deductibles/coinsurance) as other covered benefits, enforced by the Mississippi Insurance Commissioner. The bill died in committee on February 4, 2025, and did not become law, so this requirement has not been implemented. It directly affected insurers operating in Mississippi and patients relying on these nonstatin medications for cardiovascular prevention.